Ionis Pharmaceuticals Competitors and Similar CompaniesClear all

Ionis Pharmaceuticals's competitors and similar companies include Lannett, Intellia Therapeutics, Ultragenyx, Bluebird Bio, Sarepta Therapeutics, Reata Pharmaceuticals, Arrowhead Pharmaceuticals and Alnylam.
Ionis Pharmaceuticals
Ionis Pharmaceuticals
Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.
Lannett
Lannett
Lannett is a company that specializes in pharmaceutical product families.
Intellia Therapeutics
Intellia Therapeutics
Intellia Therapeutics is a genome editing company that caters to the biotechnology industry.
Ultragenyx
Ultragenyx
Ultragenyx Pharmaceutical is a company that develops therapies for rare genetic diseases.
Bluebird Bio
Bluebird Bio
Bluebird Bio is a developer of gene therapies for severe genetic diseases.
Sarepta Therapeutics
Sarepta Therapeutics
Sarepta Therapeutics is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapeutics, gene therapy and, other genetic therapeutic modalities for the treatment of rare diseases.
Reata Pharmaceuticals
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops therapeutics for patients with serious or life-threatening diseases.
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biopharmaceutical company that specializes in drug development.
Alnylam
Alnylam
Alnylam is a biopharmaceutical company that develops ribonucleic acid interference (RNAi) therapeutics for hepatic porphyria, primary hyperoxaluria type 1 (PH1), cardiovascular, and polyneuropathy treatments.
Founding Date
Founding Date
1989
Founding Date
1942
Founding Date
2014
Founding Date
2010
Founding Date
1992
Founding Date
1980
Founding Date
2002
Founding Date
2001
Founding Date
2002
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Carlsbad, US HQ
Locations
Trevose, US HQ
Philadelphia, US
Locations
Cambridge, US HQ
Locations
Novato, US HQ
Buenos Aires, AR
São Paulo, BR
Bogotá, CO
Paris, FR
Berlin, DE
Tokyo, JP
see more
Locations
Somerville, US HQ
Locations
Cambridge, US HQ
Dublin, IE
Zug, CH
Providence, US
Locations
Plano, US HQ
Irving, US
Plano, US
Locations
Pasadena, US HQ
Madison, US
San Diego, US
Locations
Cambridge, US HQ
Paris, FR
Milan, IT
Tokyo, JP
Amsterdam, NL
Stockholm, SE
Zug, CH
see more
Employees
Employees
92716% increase
Employees
56031% decrease
Employees
40323% decrease
Employees
1,2763% decrease
Employees
32338% decrease
Employees
1,31413% increase
Employees
3217% decrease
Employees
13416% increase
Employees
1,32324% increase
Valuation ($)
Valuation ($)
6.3 b
Valuation ($)
7.4 m
Valuation ($)
1.7 b
Valuation ($)
4.9 b
Valuation ($)
95.4 m
Valuation ($)
12.4 b
Valuation ($)
6.6 b
Valuation ($)
2.5 b
Valuation ($)
36.5 b

Financial

Revenue (est.)
Revenue (est.)
$705.1m (FY, 2024)
Revenue (est.)
$340.6m (FY, 2022)
Revenue (est.)
$57.9m (FY, 2024)
Revenue (est.)
$560.2m (FY, 2024)
Revenue (est.)
$83.8m (FY, 2024)
Revenue (est.)
$1.9b (FY, 2024)
Revenue (est.)
$2.2m (FY, 2022)
Revenue (est.)
$3.6m (FY, 2024)
Revenue (est.)
$2.2b (FY, 2024)
Cost of goods
Cost of goods
$11.2m (FY, 2024)
Cost of goods
$294.5m (FY, 2022)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$89.4m (FY, 2024)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$306.5m (FY, 2024)
Gross profit
Gross profit
$693.9m (FY, 2024)
Gross profit
$33.2m (FY, 2022)
Gross profit
N/A
Gross profit
N/A
Gross profit
($5.6m) (FY, 2024)
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Gross profit
$1.9b (FY, 2024)
Net income
Net income
($453.9m) (FY, 2024)
Net income
($231.6m) (FY, 2022)
Net income
($519m) (FY, 2024)
Net income
($569.2m) (FY, 2024)
Net income
($240.7m) (FY, 2024)
Net income
$235.2m (FY, 2024)
Net income
($311.9m) (FY, 2022)
Net income
($609.7m) (FY, 2024)
Net income
($278.2m) (FY, 2024)

Operating

Patents Issued
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
N/A
Patents Issued
240 (FY, 2016)
Patents Issued
359 (FY, 2016)
Patents Issued
N/A
Phase I Trials Products
Phase I Trials Products
1 (FY, 2023)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
2 (FY, 2016)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase II Trials Products
Phase II Trials Products
13 (FY, 2023)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
4 (FY, 2016)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase III Trials Products
Phase III Trials Products
9 (FY, 2023)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
1 (FY, 2016)
Phase III Trials Products
N/A
Phase III Trials Products
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 200.1m
Total funding raised
$ 409m
Total funding raised
N/A
Total funding raised
$ 468.9m
Total funding raised
$ 147.1m
Total funding raised
$ 1.5b
For sources of this data, please see the company profile

View Company Profiles

Lannett
HQ
Trevose, US
Employees
560↓ 31% decrease

Lannett is a company that specializes in pharmaceutical product families.

View company
Intellia Therapeutics
HQ
Cambridge, US
Employees
403↓ 23% decrease

Intellia Therapeutics is a genome editing company that caters to the biotechnology industry.

View company
Ultragenyx
HQ
Novato, US
Employees
1,276↓ 3% decrease

Ultragenyx Pharmaceutical is a company that develops therapies for rare genetic diseases.

View company
Bluebird Bio
HQ
Somerville, US
Employees
323↓ 38% decrease

Bluebird Bio is a developer of gene therapies for severe genetic diseases.

View company